An interventional study of Neutral shape of bronchial tip and Bent shape of bronchial tip in Double Lumen Tube Intubation, sponsored by Seoul National University Hospital. Completed at 1 site in South Korea. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2015-05-22.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention
The purpose of this study is to investigate whether flexion of bronchial tip of a left-sided double lumen endobronchial tube prevents tube misplacement to the right mainstem bronchus.
Seoul National University Hospital is the lead sponsor of 1,898 studies on the registry; 274 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Neutral shape of bronchial tip
Device: Bent shape of bronchial tip
Intubation is performed without transforming the shape of the bonchial tipof a double lumen tube.
Intubation is performed with the double lumen tube, which bronchial tip has been bent 45 degrees and maintained for 5 min.
Number of participants with intubation to right mainstem bronchus
Time frame: An expected average of 5minutes after intubation
Number of participants with airway injury
Time frame: An expected average of 5 minutes after bilateral lung ventilation
This study is completed, as verified in May 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital →